Changzhou Qianhong Bio-Pharma Co., Ltd. engages in the manufacture and sale of enzyme and polysaccharide bio-pharmaceuticals products in China. The company principally offers APLS, tablets, capsules, granules, injections, and lyophilized powder for injection covering a category of kallidinogenase, L-asparaginase, Elastase Heparin, and LMW Heparin. Its principal API comprises heparin sodium and heparin calcium offered in injectable, topical, and crude grades; and finished formulations consist of heparin sodium injection and LMW heparin pre-filled syringe. The company exports its products primarily to Europe, North America, South America, and southeast Asia. Changzhou Qianhong Bio-Pharma Co., Ltd. was founded in 1971 and is based in Changzhou, China.